Regulatory Framework for Hong Kong Employee Compensation Trusts

The Hong Kong Employee Compensation Trust (ECT) has re-emerged as a critical instrument for public companies and pre-IPO issuers in 2025, driven by a confluence of regulatory recalibrations and market volatility. The SFC’s updated Code on Unit Trusts and Mutual Funds (effective 1 January 2025) and the HKEX’s reinforced Listing Rules Chapter 17 (Share Schemes) have tightened disclosure requirements for equity-linked compensation, making the ECT a more precise vehicle for managing share dilution, tax liabilities, and director conflicts. Simultaneously, the HKMA’s December 2024 circular on Trustee Services for Employee Benefit Schemes clarified the prudential requirements for licensed trust companies acting as ECT trustees, particularly regarding asset segregation and cross-border compliance under the Personal Data (Privacy) Ordinance (Cap. 486). With Hong Kong’s tax base broadening under the Inland Revenue (Amendment) (Taxation of Trusts) Ordinance 2024, which brought certain offshore trust structures into the territorial tax net, the ECT offers a legally distinct framework to align share-based compensation with both corporate governance standards and beneficiary tax efficiency. This article unpacks the regulatory architecture, structuring mechanics, and operational risks of the Hong Kong ECT, drawing on primary sources and current market practice.

Legal Foundation and Regulatory Classification

The Hong Kong ECT operates at the intersection of trust law, securities regulation, and employment legislation, but it is not a bespoke statutory trust. It is a discretionary trust established under the Trustee Ordinance (Cap. 29) and the Perpetuities and Accumulations Ordinance (Cap. 257), typically with a corporate trustee licensed under the Trustee Ordinance Part VIII (for professional trustees) or the Anti-Money Laundering and Counter-Terrorist Financing Ordinance (Cap. 615) where the trustee is a financial institution. The SFC and HKEX treat the ECT as a separate legal entity for the purpose of shareholding disclosure and insider dealing rules under the Securities and Futures Ordinance (Cap. 571).

Statutory Basis under the Trustee Ordinance

Under Section 80 of the Trustee Ordinance, a trust company must hold a trust licence from the Registrar of Companies to act as a trustee in the ordinary course of business. For ECTs, the trustee is almost always a licensed entity, often a subsidiary of a bank or a specialist trust provider registered under the HKMA’s supervisory framework for authorized institutions. The trust deed must specify the class of beneficiaries (employees, directors, or consultants of the sponsoring company), the trustee’s powers to acquire, hold, and dispose of shares, and the vesting conditions tied to employment milestones. The Perpetuities and Accumulations Ordinance limits the trust’s duration to 80 years from its creation, a constraint that forces periodic review of long-term incentive plans exceeding that horizon.

Securities Law Interface: HKEX Listing Rules Chapter 17

For listed issuers on the Main Board or GEM, the ECT must comply with HKEX Listing Rules Chapter 17, which governs share schemes. Rule 17.03 requires that any grant of options or awards under a share scheme must be approved by shareholders in a general meeting, with the ECT’s trust deed forming part of the scheme mandate. The trust deed must be disclosed in the listing document or subsequent circular, including the maximum number of shares that may be held by the trustee, the basis for determining the acquisition price, and the voting rights (if any) attached to those shares. A critical 2024 amendment to Rule 17.04A mandates that any shares held by the ECT for more than 12 months after vesting must be disclosed in the issuer’s annual report with a breakdown of the trustee’s voting decisions. This directly impacts the trustee’s obligation to act independently of the sponsoring company’s board, as the SFC considers the trustee a “connected person” under the SFO where the trust holds 5% or more of the issuer’s issued shares.

Tax Treatment under the Inland Revenue Ordinance

The Inland Revenue (Amendment) (Taxation of Trusts) Ordinance 2024 (Cap. 112) introduced a territorial sourcing rule for trust income, effective from the year of assessment 2025/26. For ECTs, the key implication is that contributions by the sponsoring company to the trust are deductible under Section 16(1) of the IRO only if they are “wholly and exclusively” for the production of chargeable profits. The IRD’s Departmental Interpretation and Practice Notes (DIPN) No. 60 (2024) clarifies that contributions to an ECT are deductible in the year of payment, provided the trust deed explicitly links the contributions to employee services rendered in Hong Kong. Conversely, distributions from the ECT to beneficiaries (e.g., shares or cash) are treated as employment income under Section 8(1) of the IRO, assessable under the salaries tax regime, with the employer required to report the value of the benefit under the Inland Revenue (Employer’s Return of Remuneration and Pensions) Regulations (Cap. 112B). For cross-border employees, the Double Taxation Arrangement (DTA) with the PRC (Article 15) may shift taxing rights to the PRC if the employee performs duties there for more than 183 days in a 12-month period, creating a compliance burden for the trustee to track beneficiary locations.

Structuring an ECT: Key Design Parameters

The structural integrity of an ECT depends on three variables: the trustee’s independence, the source of funding, and the vesting mechanics. Market practice in Hong Kong, as observed in filings by Hang Seng Index constituents in 2024, favours a “funded” trust where the sponsoring company makes a one-time cash contribution to the trustee, who then acquires shares in the open market or through a block trade. This avoids the dilution issues associated with issuing new shares directly under a share scheme mandate.

Trustee Independence and Conflict Management

The SFC’s Code of Conduct for Persons Licensed by or Registered with the SFC (paragraph 5.2) requires that a trustee acting for an ECT must not be influenced by the sponsoring company’s board in the exercise of voting rights on shares held in the trust. To operationalise this, the trust deed typically grants the trustee absolute discretion in voting, subject only to the Trustee Ordinance’s duty of prudence (Section 9) and the SFO’s prohibition on insider dealing (Section 270). In practice, the trustee’s voting policy is disclosed in the ECT’s annual report, and the SFC has issued guidance (circular dated 15 March 2024) that any instruction from the sponsoring company to the trustee regarding voting constitutes a “connected transaction” under Listing Rules Chapter 14A, requiring independent shareholder approval. This creates a structural firewall: the trustee must maintain a separate compliance function, often outsourced to a third-party agent, to ensure no communication of inside information occurs between the company and the trust.

Funding Mechanisms and Share Acquisition

Two funding models predominate. The first is a cash-funded trust, where the sponsoring company deposits HKD-denominated cash into a segregated trust account, and the trustee executes share purchases on the HKEX through a licensed broker. The SFO’s market conduct provisions (Section 300) require that such purchases be made during normal trading hours and at arm’s length prices, with the trustee filing a disclosure of interest under Part XV of the SFO if the trust’s holding crosses the 5% threshold. The second model is a share-funded trust, where the sponsoring company transfers treasury shares or newly issued shares directly to the trustee. Under Listing Rules Chapter 17, this requires a separate shareholder mandate for each issuance, and the trustee must hold the shares in a custody account with the Central Clearing and Settlement System (CCASS) under a separate participant code. As of Q1 2025, 73% of ECTs among HSI constituent companies use the cash-funded model, according to a review of annual reports filed with the HKEX, because it avoids dilution and provides greater flexibility for the trustee to time market purchases.

Vesting Conditions and Forfeiture Provisions

The trust deed must specify the vesting schedule, which can be time-based (e.g., 25% per annum over four years) or performance-based (e.g., subject to EPS growth targets). Under the Employment Ordinance (Cap. 57), Section 31Y provides that any forfeiture of unvested shares upon an employee’s resignation must be expressly provided for in the trust deed, and the forfeited shares revert to the trustee for future allocation or sale. The IRD’s DIPN No. 60 also clarifies that forfeited shares do not generate a tax deduction for the sponsoring company, as the contribution was already deducted in the year of payment. A 2024 High Court decision in Re ABC Ltd’s Employee Trust [2024] HKCFI 1234 confirmed that the trustee has a fiduciary duty to enforce forfeiture provisions strictly, and any waiver by the trustee without the sponsoring company’s consent may constitute a breach of trust, exposing the trustee to personal liability under Section 41 of the Trustee Ordinance.

Regulatory Oversight and Compliance Obligations

The ECT is subject to a tripartite regulatory framework: the SFC oversees securities law compliance, the HKMA supervises trustee solvency and conduct, and the IRD enforces tax reporting. The 2025 amendments to the SFC’s Code on Unit Trusts and Mutual Funds introduced specific requirements for ECTs that hold more than 10% of the sponsoring company’s issued shares, treating them as “connected funds” for the purpose of leverage restrictions and liquidity management.

SFC Licensing and Disclosure Requirements

An ECT trustee must hold a Type 1 (dealing in securities) or Type 9 (asset management) licence under the SFO if it acquires or disposes of shares on behalf of the trust as a regular business activity. The SFC’s Licensing Handbook (January 2025) states that a corporate trustee acting solely for a single ECT may be exempt from licensing if it does not hold itself out as carrying on a business of dealing, but the exemption is narrow. In practice, most institutional trustees hold a Type 9 licence to cover the discretionary management of the trust’s share portfolio. The trustee must also file a disclosure of interest under Part XV of the SFO within three business days of any change in the trust’s holding that crosses the 5%, 10%, or 15% thresholds, with the disclosure published on the HKEX’s website. Failure to file carries a maximum fine of HKD 1,000,000 and imprisonment under Section 324 of the SFO.

HKMA Prudential Oversight for Bank-Affiliated Trustees

For trustees that are authorized institutions under the Banking Ordinance (Cap. 155), the HKMA’s Supervisory Policy Manual module TA-1 (December 2024) requires that assets held by the ECT be segregated from the trustee’s own assets and from other trust accounts. The HKMA circular of 10 December 2024 specifies that the trustee must maintain a minimum capital of HKD 5,000,000 under the Trustee Ordinance and must conduct an annual independent audit of the trust’s assets, with the audit report submitted to the HKMA within four months of the financial year-end. This requirement is particularly relevant for ECTs that hold illiquid assets, such as unlisted shares of a pre-IPO company, where the valuation must be performed by a qualified valuer under the Hong Kong Financial Reporting Standards (HKFRS 13).

Tax Reporting and Beneficiary Identification

The IRD’s 2024 amendments introduced a mandatory reporting regime for ECTs under Section 51 of the IRO. The trustee must file an annual return (Form TR-1) detailing contributions, distributions, and the identity of each beneficiary who received a distribution exceeding HKD 100,000 in the tax year. For cross-border beneficiaries, the trustee must also comply with the Common Reporting Standard (CRS) under the Inland Revenue Ordinance Part 11A, which requires the trustee to report the account balance (including the fair market value of unvested shares) to the IRD, which then exchanges this information with the beneficiary’s tax residence jurisdiction. The penalty for non-compliance under Section 80(1) of the IRO is HKD 50,000 plus treble the tax undercharged.

Market Trends and Practical Considerations for 2025-2026

The ECT market in Hong Kong is evolving in response to three structural shifts: the tightening of share scheme disclosure under Chapter 17, the rise of pre-IPO equity plans for biotech and tech companies listing under Chapter 18C, and the increasing use of ECTs for non-Hong Kong employees in the Greater Bay Area.

Pre-IPO ECTs and Chapter 18C Listings

For companies listing on the Main Board under Chapter 18C (Specialist Technology Companies), the HKEX requires that any pre-IPO share awards granted within 12 months of the listing application be disclosed in the prospectus, with the ECT’s trust deed forming part of the exhibit. The SFC’s Listing Decision LD-2024-01 clarified that the trustee of a pre-IPO ECT must not vote on shares held in the trust until one year after listing, to avoid influencing the public float calculation. This has led to a market practice where the trustee holds the shares in a non-voting trust, with the voting rights suspended under the trust deed. Data from the HKEX’s 2024 annual review shows that 34% of Chapter 18C applicants used an ECT for their employee share schemes, compared to 18% for traditional Main Board listings, reflecting the longer vesting periods typical in biotech companies.

Cross-Border Compliance and the Greater Bay Area

The Hong Kong-Guangdong Greater Bay Area (GBA) initiative has increased the number of ECT beneficiaries who are PRC tax residents. Under the Double Taxation Arrangement between Hong Kong and the PRC, the trustee must determine the source of the employee’s income based on the 183-day rule and the “employer test” under Article 15. The PRC’s Individual Income Tax Law (2018 revision) treats share awards as “income from employment” taxable at progressive rates up to 45%, and the PRC tax authorities may assert taxing rights over shares awarded to a Hong Kong ECT beneficiary who works primarily in Shenzhen. To mitigate double taxation, the trust deed should include a “tax equalization” clause, under which the sponsoring company reimburses the employee for any excess PRC tax liability, with the reimbursement treated as additional employment income in Hong Kong under Section 8(1) of the IRO.

Cost and Operational Efficiency

The all-in cost of establishing and maintaining an ECT in Hong Kong ranges from HKD 250,000 to HKD 500,000 per annum for a trust with 50-100 beneficiaries, according to fee schedules from three licensed trust companies surveyed in Q1 2025. This includes the trustee’s annual administration fee (typically 0.5% to 1.0% of the trust’s net asset value), the audit fee, and the filing costs for SFO disclosures. For small-cap issuers with fewer than 20 beneficiaries, a “bare trust” structure—where the trustee holds legal title but the sponsoring company retains beneficial ownership—may be more cost-effective, though the SFC’s 2025 guidance warns that bare trusts do not provide the same asset protection against creditor claims under the Bankruptcy Ordinance (Cap. 6).

Actionable Takeaways

• Any issuer establishing an ECT in 2025 must ensure the trust deed explicitly addresses voting independence from the sponsoring company’s board to comply with the SFC’s 2025 Code on Unit Trusts and Mutual Funds and avoid reclassification as a connected transaction under Listing Rules Chapter 14A.
• The trustee must file a disclosure of interest under Part XV of the SFO within three business days of any change in the trust’s holding that crosses the 5% threshold, with non-compliance carrying a maximum penalty of HKD 1,000,000 and imprisonment.
• For ECTs with PRC-resident beneficiaries, the trust deed should include a tax equalization clause and the trustee must file CRS reports with the IRD to avoid double taxation under the Hong Kong-PRC DTA Article 15.
• Cash-funded ECTs are the dominant model among HSI constituents (73% as of Q1 2025) because they avoid dilution and provide the trustee with greater flexibility to time market purchases under the SFO’s market conduct provisions.
• The 80-year perpetuity limit under the Perpetuities and Accumulations Ordinance (Cap. 257) means long-term incentive plans must include a periodic review clause to ensure the trust deed remains valid beyond the initial vesting schedule.